{"slideshow_credits": null, "snippet": "Elizabeth Holmes built Theranos into a company valued at $9 billion, with help from some powerful family connections, but its successes have been fleeting.", "abstract": "Theranos founder and chief executive Elizabeth Holmes is attempting to rescue reputation of company and its blood testing technology; Food and Drug Administration is requiring equipment and tests to submit to regulatory process for approval; Holmes' challenge is to convince FDA and consumers of products' efficacy.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Reed", "role": "reported", "lastname": "ABELSON", "rank": 1, "organization": ""}, {"firstname": "Julie", "role": "reported", "lastname": "CRESWELL", "rank": 2, "organization": ""}], "original": "By REED ABELSON and JULIE CRESWELL", "contributor": "Andrew Pollack, Katie Benner and Doris Burke contributed reporting."}, "web_url": "http://www.nytimes.com/2015/12/20/business/theranos-founder-faces-a-test-of-technology-and-reputation.html", "lead_paragraph": "Elizabeth Holmes built Theranos into a company valued at $9 billion, with help from some powerful family connections, but its successes have been fleeting.", "headline": {"main": "Theranos Founder Faces a Test of Technology, and Reputation", "print_headline": "Theranos Founder Faces Ultimate Test of Mission"}, "_id": "5675914c38f0d82604f362ea", "word_count": "2876", "multimedia": [{"height": 126, "url": "images/2015/12/20/business/20THERANOS/20THERANOS-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/12/20/business/20THERANOS/20THERANOS-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 1056, "url": "images/2015/12/20/business/20THERANOS/20THERANOS-articleLarge.jpg", "legacy": {"xlarge": "images/2015/12/20/business/20THERANOS/20THERANOS-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "1056"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/12/20/business/20THERANOS/20THERANOS-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/12/20/business/20THERANOS/20THERANOS-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-12-20T00:00:00Z", "source": "The New York Times", "news_desk": "SundayBusiness", "keywords": [{"name": "organizations", "value": "Theranos Inc", "is_major": "Y", "rank": "1"}, {"name": "persons", "value": "Holmes, Elizabeth (1984- )", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Tests (Medical)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "4"}, {"name": "subject", "value": "Blood", "is_major": "Y", "rank": "5"}, {"name": "subject", "value": "Venture Capital", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}